Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 9Thoracic 2Sarcoma 2NET 1Head & Neck 1Gynecologic 1Genitourinary 1Endocrine 1CNS 1Breast 1

Conditions

Lung Neoplasms 102Carcinoma, Non-Small-Cell Lung 84Breast Neoplasms 16Neoplasm Metastasis 14Melanoma 14Brain Neoplasms 14Small Cell Lung Carcinoma 13Esophageal Neoplasms 10Colorectal Neoplasms 9Carcinoma, Renal Cell 9Pancreatic Neoplasms 8Ovarian Neoplasms 8Adenocarcinoma of Lung 8Prostatic Neoplasms 7Carcinoma, Hepatocellular 7Colonic Neoplasms 6Stomach Neoplasms 5Carcinoma, Transitional Cell 5Uterine Cervical Neoplasms 4Triple Negative Breast Neoplasms 4Thyroid Neoplasms 4Sarcoma, Kaposi 4Rectal Neoplasms 4Meningeal Carcinomatosis 4Squamous Cell Carcinoma of Head and Neck 3Neoplasms 3Lymphoma 3Head and Neck Neoplasms 3HIV Infections 3Carcinoma, Medullary 3

Interventions

pembrolizumab 5tislelizumab 2spartalizumab 2Trastuzumab 2Psychiatric Rehabilitation 2Nivolumab 2Magnetic Resonance Spectroscopy 2Interleukin-12 Subunit p35 2Erlotinib Hydrochloride 2Biopsy 2trastuzumab deruxtecan 1tipifarnib 1regorafenib 1prexasertib 1niraparib 1fludarabine 1enzalutamide 1entinostat 1abiraterone 1Vorinostat 1Thalidomide 1Taxes 1Surveys and Questionnaires 1Specimen Handling 1Ritonavir 1Radiotherapy 1Radionuclide Imaging 1Quality of Life 1Patient Reported Outcome Measures 1Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Anus Neoplasms × Magnetic Resonance Spectroscopy × Thoracic × Clear all
NCT02408861 2026-01-21

Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 1 Terminated
79 enrolled 24 charts
GastrointestinalSarcomaThoracic

Anus Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Sarcoma, Kaposi, HIV Infections

NCT07118176 2025-08-12

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

Jonsson Comprehensive Cancer Center

Phase 1 Recruiting
30 enrolled
BreastCNSEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckNETSarcomaThoracic

Adrenal Gland Neoplasms, Anus Neoplasms, Urinary Bladder Neoplasms, Brain Neoplasms, Breast Neoplasms, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Penile Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Stomach Neoplasms, Testicular Neoplasms, Thyroid Neoplasms, Uterine Neoplasms, Vaginal Neoplasms, Colorectal Neoplasms, Carcinoma, Medullary, Cholangiocarcinoma, Neuroendocrine Tumors, Solitary Fibrous Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡